Health
Biotech Industry Faces Setbacks
Two recent developments in the biotech industry highlight ongoing challenges. STAT News reports that a biotech hedge fund is launching a new company to develop an improved treatment for atopic dermatitis, while another study by Sellas is expected to fail.
Coverage timeline — 2 articles
STAT News
Why a biotech hedge fund decided to build from the ground up a new company to develop a better, long-acting antibody treatment for atopic dermatitis.
2026-09-17 10:30 UTC
STAT News
Why Sellas' experimental immunotherapy study is a blowup waiting to happen.
2026-09-17 10:30 UTC